Journal of agricultural medicine and community health (농촌의학ㆍ지역보건)

Korean Society for Rural Medicine and Community Health (한국농촌의학지역보건학회)
권호 표지
DOI QR코드

DOI QR Code

Medical Expenditure Attributable to Overweight and Obesity in Adults with Hypertension, Diabetes and Dyslipidemia : Evidence from Korea National Health and Nutrition Examination Survey Data and Korea National Health Corporation Data

성인의 고혈압, 당뇨병, 이상지질혈증으로 인한 총 진료비 중 과체중 및 비만의 기여분 : 국민건강영양조사자료와 국민건강보험공단 자료를 중심으로

  • Kang, Jae-Heon (Department of Family Medicine, Seoul Paik Hospital, College of Medicine, Inje University) ;
  • Jeong, Baek-Geun (Department of Preventive Medicine, College of Medicine, Gyeongsang National University & Institute of Health Science) ;
  • Cho, Young-Gyu (Department of Family Medicine, Seoul Paik Hospital, College of Medicine, Inje University) ;
  • Song, Hye-Ryoung (Department of Family Medicine, College of Medicine, Eulji University) ;
  • Kim, Kyung-A (Institute for Clinical Nutrition, Inje University)
  • 강재헌 (인제대학교 서울백병원 가정의학과) ;
  • 정백근 (경상대학교 의학전문대학원 예방의학교실 및 건강과학연구원) ;
  • 조영규 (인제대학교 서울백병원 가정의학과) ;
  • 송혜령 (을지대학교 의과대학 가정의학교실) ;
  • 김경아 (인제대학교 임상영양 연구소)
  • Received : 2009.12.14
  • Accepted : 2010.02.18
  • Published : 2010.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study was conducted to estimate medical expenditure attributable to overweight and obesity in adults with hypertension, diabetes and dyslipidemia using Korea National Health and Nutrition Examination survey data and Korea National Health Corporation data. Methods: The medical expenditure of hypertension, diabetes and dyslipidemia related to overweight and obesity were composed of inpatient care costs, outpatient care costs and medication costs. The population attributable risk (PAR) of overweight and obesity was calculated from national representative data of Korea such as the National Health Insurance Corporation cohort data and 2005 Korea National Health and Nutrition Examination survey data. Results: The medical expenditure attributable to overweight and obesity of hypertension were 456 billion won (men : 215 billion won, women : 241 billion won). Those of diabetes were 282 billion won (men : 148 billion won, women : 135 billion won), and of dyslipidemia were 17 billion won (men : 9 billion won, women : 8 billion won). Consequently, these costs corresponded to 33.3% of total medical expenditure due to hypertension, diabetes and dyslipidemia. Conclusions: We found a substantial medical expenditure due to overweight and obesity of hypertension, diabetes and dyslipidemia were very high. In order to reduce these costs, effective national strategies for prevention and management of overweight and obesity should be established and implemented.

이 연구는 고혈압, 당뇨병, 이상지질혈증으로 지출된 진료비 중 과체중 및 비만의 기여분을 추계하기 위한 질병비용연구로서 국민건강보험공단의 건강검진 및 건강보험급여 자료를 활용한 연구이다. 연구결과 2005년 현재 고혈압, 당뇨병, 이상지질혈증 때문에 지출된 총 진료비 중 과체중 및 비만의 기여분은 각각 4,561억원(4,328억원-4,805억원), 2,823억원(2,487억원-3,176억원), 165억원(147억원-183억원)이었고, 이를 모두 합하면 7,549억원(6,961억원-8,164억원)이었다. 이는 해당 연도의 고혈압 총 진료비의 34.6%(32.9%-36.5%), 당뇨병 총 진료비의 32.5%(28.6%-36.6%), 이상지질혈증 총 진료비의 19.4%(17.3%-21.6%)를 차지한다. 또한 이 세 가지 질병의 총 진료비를 기준으로 했을 때 과체중 및 비만이 기여한 금액은 33.3%(30.7%-36.0%)에 해당하였다. 이는 과체중과 비만을 예방한다면 고혈압, 당뇨병, 이상지질혈증으로 지출되는 총 진료비의 33.3%를 감소시킬 수 있다는 의미이며, 향후 만성질환 예방과 관련하여 과체중 및 비만의 예방관리사업이 얼마나 중요한가를 시사해 주는 것이다.

Keywords

References

  1. Bonow RO, Smaha LA, Smith SC Jr, Mensah GA, Lenfant C. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 2002;106:1602-1605. https://doi.org/10.1161/01.CIR.0000035036.22612.2B
  2. WHO. Obesity-preventing and managing the global epidemic. World Health Organization: Geneva, 1997.
  3. Park SH, Choi SJ, Lee KS, Park HY. Waist circumference and waist-to-height ratio as predictors of cardiovascular disease risk in Korean adults. Circ J 2009;73:1643-1650. https://doi.org/10.1253/circj.CJ-09-0161
  4. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolscent, and adults, 1999-2002. JAMA 2004;291:2847-2850. https://doi.org/10.1001/jama.291.23.2847
  5. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-977. https://doi.org/10.1161/01.CIR.67.5.968
  6. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: A new world-wide definition: A Consensus Statement from the International Diabetes Federation. Diabe Med 2006;23:469-480. https://doi.org/10.1111/j.1464-5491.2006.01858.x
  7. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
  8. Hsieh SD, Yoshinaga H. Waist/height ratio as a simple and useful predictor of coronary heart disease risk factors in women. Intern Med 1995;34:1147-1152. https://doi.org/10.2169/internalmedicine.34.1147
  9. Hsieh SD, Yoshinaga H. Abdominal fat distribution and coronary heart disease risk factors in men-waist/height ratio as a simple and useful predictor. Int J Obes Relat Metab Disord 1995;19:585-589.
  10. United States. Dept. of Health and Human Services. Healthy people 2010: understanding and improving health. Rev. ed. Boston: Jones and Bartlett Publishers; 2001.
  11. 서미경, 김혜련, 서동우, 선우덕, 신윤정, 최은진, 최정수, 황나미. 새국민건강증진계획수립. 보건복지부, 한국보건사회연구원; 2006, 305-323쪽
  12. 보건복지가족부 질병정책과. 2009년도 주요 만성질환관리사업 안내; 2009.
  13. Swinburn B, Ashton T, Gillespie J, Cox B, Menon A, Simmons D, Birkbeck J. Health care costs of obesity in New Zealand. Int J Obes Relat Metab Disord 1997;21(10):891-896. https://doi.org/10.1038/sj.ijo.0800486
  14. Birmingham CL, Muller JL, Palepu A, Spinelli JJ, Anis AH. The cost of obesity in Canada. CMAJ 1999;160:483-488.
  15. Zhao W, Zhai Y, Hu J, Wang J, Yang Z, Kong L, Chen C. Economic burden of obesity-related chronic diseases in Mainland China. Obes Rev. 2008;9 Suppl 1:62-67. https://doi.org/10.1111/j.1467-789X.2007.00440.x
  16. Jeong BG, Moon OR, Kim NS, Kang JH, Yoon TH, Lee SY, Lee SJ. Socioeconomic costs of obesity for Korean adults. Korean J Prev Med 2002;35(1):1-12(Korean).
  17. 김정희, 정종찬, 이호용, 최숙자, 이진경. 2005년도 건강보험환자의 본인부담 진료비 실태조사. 국민건강보험공단; 2006.
  18. Khan LK, Sobush K, Keener D, Goodman K, Lowry A, Kakietek J, Zaro S. Recommended community strategies and measurements to prevent obesity in the United States. MMWR Recomm Rep. 2009;58(RR-7):1-26.
  19. Kantachuvessiri A. Obesity in Thailand. J Med Assoc Thai 2005;88(4):554-562.
  20. Ismail MN, Chee SS, Nawawi H, Yusoff K, Lim TO, James WPT. Obesity in Malaysia. Obes Rev 2002;3(3):203-208. https://doi.org/10.1046/j.1467-789X.2002.00074.x
  21. Ginter E, Simko V. Adult obesity at the beginning of the 21st century: epidemiology, pathophysiology and health risk. Bratisl Lek Listy 2008;109(5):224-230.
  22. Kim NS, Moon OR, Kang JH, Lee SY, Jeong BG, Lee SJ, Yoon TH, Hwang KH. Increasing prevalence of obesity related disease for Koreans associated with overweight and obesity. Korean J Prev Med 2001;34(4):309-315(Korean).
  23. Bjornelv S, Lydersen S, Holmen J, Lund Nilsen TI, Holmen TL. Sex differences in time trends for overweight and obesity in adolescents: The Young-HUNT study. Scand J Public Health. 2009;37(8):881-889. https://doi.org/10.1177/1403494809347022
  24. Fu T, Wen T, Yeh P, Chang H. Costs of metabolic syndrome - related diseases induced by obesity in Taiwan. Obes Rev. 2008;9 suppl 1:68-73. https://doi.org/10.1111/j.1467-789X.2007.00441.x
  25. Drummond MF. Principles of economic appraisal in health care. Oxford University, 1980, pp10-12.
  26. Jarl J, Johansson P, Eriksson A, Eriksson M, Gerdtham U, Hemstro O, Hradilova Selin KH, Lenke L, Ramstedt M, Room R. The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002. Eur J Health Econ 2008;Nov;9(4):351-360. https://doi.org/10.1007/s10198-007-0082-1
  27. Casado V, Romero L, Gubieras L, Alonso L, Moral E, Martinez-Yelamos S, Martinez-Yelamos A, Carmona O, Arbizu T. An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain. Multiple Sclerosis 2007;13:800-804. https://doi.org/10.1177/1352458506073480
  28. Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff 2003;Suppl Web Exclusives:W3-219-26. https://doi.org/10.1377/hlthaff.w3.219
  29. Thompson D, Wolf AM. The medical-care cost burden of obesity. Obes Rev 2001;2:189-97. https://doi.org/10.1046/j.1467-789x.2001.00037.x
  30. Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff(Millwood) 2002;21(2):245-53. https://doi.org/10.1377/hlthaff.21.2.245

Cited by

  1. Evaluation of nutrient and food intake status, and dietary quality according to abdominal obesity based on waist circumference in Korean adults: Based on 2010-2012 Korean National Health and Nutrition Examination Survey vol.47, pp.6, 2014, https://doi.org/10.4163/jnh.2014.47.6.403
  2. Prevalence of Hypertension and Related Risk Factors in the Elderly: Data from the 4th Korean National Health & Nutrition Examination Survey, 2007~2009 vol.19, pp.1, 2013, https://doi.org/10.14373/JKDA.2013.19.1.014
  3. Evaluation of the Effectiveness of Dietary Education and Exercise Program on Obese Adults in Chuncheon Area vol.32, pp.1, 2016, https://doi.org/10.9724/kfcs.2016.32.1.123
  4. Comparison of Chronic Disease Risk by Abdominal Obesity in Korean Adult Women - Using Data from the 2013~2014 Korea National Health and Nutrition Examination Survey - vol.29, pp.6, 2016, https://doi.org/10.9799/ksfan.2016.29.6.938
  5. The Cumulative Recurrence Rate of Colonic Adenomatous Polyps After Colon Polypectomy in a Single University Hospital Health Check-up Examinees vol.39, pp.3, 2014, https://doi.org/10.5393/JAMCH.2014.39.3.137
  6. Antidiabetic Effects of Gastric Banding Surgery in Morbidly Obese Patients with Type 2 Diabetes Mellitus vol.6, pp.3, 2017, https://doi.org/10.7762/cnr.2017.6.3.206